RAMES study: is there really a role for VEGF inhibition in mesothelioma? - Authors' reply.

Zucali, Paolo Andrea; Pinto, Carmine; Ceresoli, Giovanni Luca

Zucali, Paolo Andrea; Pinto, Carmine; Ceresoli, Giovanni Luca.

Zucali PA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Department of Oncology, IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy. Electronic address: paolo.zucali@hunimed.eu.
Pinto C; Medical Oncology Unit, Clinical Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Ceresoli GL; Thoracic and GU Oncology Unit, Department of Medical Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy.

Lancet Oncol ; 22(12): e533, 2021 12.

Article en En | MEDLINE | ID: mdl-34856143

Asunto(s)

Mesotelioma Maligno; Mesotelioma; Neoplasias Pleurales; Humanos; Mesotelioma/tratamiento farmacológico; Factor A de Crecimiento Endotelial Vascular

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Mesotelioma Maligno / Mesotelioma Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google